Factors That Predict Biological Aggressiveness in Estrogen Receptor–Positive / Human Epidermal Growth Factor Receptor 2–Negative / Lymph Node–Negative Breast Cancer

Background: Traditionally, breast cancer is staged using TNM criteria: tumor size (T), nodal status (N), and metastasis (M). The Oncotype DX assay provides a recurrence score (RS) based on genomics that predicts the likelihood of distant recurrence in estrogen receptor–positive (ER+)/human epidermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Arthur, Lauren E., McMann, Ashley H., Slattery, Lauren N., Fuhrman, George M., Mackey, Aimee M., Rivere, Amy E., Corsetti, Ralph L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Division of Ochsner Clinic Foundation 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755554/
https://www.ncbi.nlm.nih.gov/pubmed/33408575
http://dx.doi.org/10.31486/toj.20.0035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755554/
https://www.ncbi.nlm.nih.gov/pubmed/33408575
http://dx.doi.org/10.31486/toj.20.0035

Ejemplares similares